Floatz logo

176 assets in HER2 Positive Breast Carcinoma

Therapeutic assets addressing HER2 Positive Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pertuzumab
HER2 Positive Breast Carcinoma
SWOG Cancer Research NetworkP4BB (71)
Trastuzumab
HER2 Positive Breast Carcinoma
SWOG Cancer Research NetworkP4BB (71)
Ribociclib
HER2 Positive Breast Carcinoma
Danish Breast Cancer Cooperative GroupP3BB (69)
Capecitabine
HER2 Positive Breast Carcinoma
MedSIRP4BB (68)
Cyclophosphamide
HER2 Positive Breast Carcinoma
National University Hospital, SingaporeP3BB (68)
Docetaxel
HER2 Positive Breast Carcinoma
Ohio State University Comprehensive Cancer CenterP3BB (68)
Vinorelbine Ditartrate
HER2 Positive Breast Carcinoma
Fudan UniversityP3BB (68)
Adriamycin
HER2 Positive Breast Carcinoma
Shanghai JMT-Bio Inc.P3BB (66)
Alpelisib
HER2 Positive Breast Carcinoma
Criterium, Inc.P3BB (66)
Carboplatin
HER2 Positive Breast Carcinoma
Rutgers, The State University of New JerseyP3BB (66)
Epirubicin
HER2 Positive Breast Carcinoma
Ohio State University Comprehensive Cancer CenterP3BB (66)
Everolimus
HER2 Positive Breast Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3BB (66)
Pyrotinib
HER2 Positive Breast Carcinoma
Peking University People's HospitalP4BB (66)
Trastuzumab Emtansine
HER2 Positive Breast Carcinoma
SWOG Cancer Research NetworkP4BB (66)
Fruquintinib
HER2 Positive Breast Carcinoma
Zhongnan HospitalP4BB (65)
Zanidatamab
HER2 Positive Breast Carcinoma
MedSIRP3BB (65)
Disitamab Vedotin
HER2 Positive Breast Carcinoma
Fudan UniversityP4BB (64)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
HER2 Positive Breast Carcinoma
Haihua YuanP4BB (64)
Trastuzumab Sc
HER2 Positive Breast Carcinoma
Peking University Cancer Hospital & InstituteP3BB (64)
Abemaciclib
HER2 Positive Breast Carcinoma
Mario Negri Institute for Pharmacological ResearchP3B (63)
Lapatinib
HER2 Positive Breast Carcinoma
Deraya UniversityP3B (63)
T-Dxd
HER2 Positive Breast Carcinoma
Peking University Cancer Hospital & InstituteP2/3B (63)
Trastuzumab Deruxtecan
HER2 Positive Breast Carcinoma
SWOG Cancer Research NetworkP3B (63)
Fulvestrant
HER2 Positive Breast Carcinoma
Sun Yat-sen UniversityP3B (62)
Goserelin
HER2 Positive Breast Carcinoma
Fudan UniversityP3B (62)
Inetetamab
HER2 Positive Breast Carcinoma
Fudan UniversityP2/3B (62)
Letrozole
HER2 Positive Breast Carcinoma
Sun Yat-sen UniversityP3B (62)
Palbociclib
HER2 Positive Breast Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., LtdP2B (62)
Anbenitamab
HER2 Positive Breast Carcinoma
Shanghai JMT-Bio Inc.P3B (60)
Anti-Her2 Antibody-Drug Conjugate A166
HER2 Positive Breast Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.P3B (60)
Atezolizumab
HER2 Positive Breast Carcinoma
Samsung Medical CenterP3B (60)
Bl-M07D1
HER2 Positive Breast Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3B (60)
ds-8201a
HER2 Positive Breast Carcinoma
Daiichi SankyoP3B (60)
Fludeoxyglucose
HER2 Positive Breast Carcinoma
University of Alabama at BirminghamP2B (60)
TQB2930 for injection
HER2 Positive Breast Carcinoma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.P3B (60)
Tucatinib
HER2 Positive Breast Carcinoma
MedSIRP3B (60)
Eribulin
HER2 Positive Breast Carcinoma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.P3B (59)
Fludarabine
HER2 Positive Breast Carcinoma
National University Hospital, SingaporeP1/2B (59)
Ladiratuzumab Vedotin
HER2 Positive Breast Carcinoma
Seagen Inc.P2B (59)
Niraparib
HER2 Positive Breast Carcinoma
University of Alabama at BirminghamP2B (59)
Fluorouracilum
HER2 Positive Breast Carcinoma
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)P3B (58)
Loperamide
HER2 Positive Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP2B (58)
Oxaliplatin
HER2 Positive Breast Carcinoma
Enliven TherapeuticsP2B (58)
Tamoxifen
HER2 Positive Breast Carcinoma
University of ChicagoP3B (58)
Anastrozole
HER2 Positive Breast Carcinoma
Sun Yat-sen UniversityP3B (57)
Exemestane
HER2 Positive Breast Carcinoma
Fudan UniversityP2B (57)
hlx22
HER2 Positive Breast Carcinoma
Shanghai Henlius BiotechP2/3B (57)
HLX87
HER2 Positive Breast Carcinoma
Shanghai Henlius BiotechP2/3B (57)
Neratinib
HER2 Positive Breast Carcinoma
Fudan UniversityP3B (57)
Pegfilgrastim
HER2 Positive Breast Carcinoma
Centre Leon BerardP2B (57)
Showing 1 to 50 of 176 assets
PreviousPage 1 of 4Next